peptide glp-1 Glucagon-like 1 (GLP-1) SOLD FOR RESEARCH ONLY! Role of glucagon-like peptide (GLP-1)

GLP-1 receptor agonists have demonstrated significant anti-inflammatory properties in the central nervous system

13 DossatA

With the recent commercial success of therapies based on GLP-1, and the corresponding awareness this has created of the underlying scientific breakthroughs of the 1980s, major prize committees have begun allocating recognition for the foundational work in this field

Currently, only about 1% of patients eligible for bariatric surgery actually receive the treatment

Many patients begin with lower doses of GLP-1 drugs like Semaglutide or Tirzepatide to allow their bodies to adjust and to reduce the risk of gastrointestinal side effects, which are common with these medications

GLP-1 medications like semaglutide 2.4 mg produce approximately 14.9% average body weight reduction over 68-72 weeks